Csa Downregulates Ifn-Gamma Gene Transcription After Liver Transplantation By Inhibiting Nf-Kappa B Activity

Ck Jia,Ss Zheng,Hy Xie

IF: 6.133

2003-01-01

Chinese Medical Journal

Abstract:Objective To investigate the relationship between NF-kappaB activity and IFN-gamma gene expression, as well as the histopathological changes following liver transplants, both with and without cyclosporin A (CsA) treatment.Methods Sixty male Wistar and Thirty male SD rats were subjected to orthotopic liver transplants. Fourty-five of the Wistar rats were used as recipients, and were divided into 3 groups: group I, syngeneic control (Wistar-to-Wistar); group II, acute rejection (SD-to-Wistar); and group III : acute rejection treated with cyclosporin A by intramuscular injection (SD-to-Wistar + CSA). After the liver transplants, electrophoretic gel mobility shift assay was used to analyze NF-kappaB activity in the splenocytes of recipient rats, and RT-PCR was used to measure IFN-gamma gene expression in grafted liver specimens. In addition, histopathological examinations were performed to assess the severity of acute liver rejection.Results In group I, low levels of NF-kappaB activity were only detectable on day 5 and 7 post-transplant, and only weak IFN-gamma mRNA expression was observed at all time points. By contrast, both high NF-kappaB activity and high expression levels of IFN-gamma mRNA were detected at all time points in group II. In group III, NF-kappaB activity and IFN-gamma mRNA expression were significantly inhibited, as compared to group II (P<0.05). A good correlation was found between NF-kappa B activity and IFN-gamma mRNA expression (r=0.815). In addition, NF-kappa B activity and IFN-gamma mRNA expression mirrored histopathological changes in all three experimental groups.Conclusions Changes in IFN-gamma mRNA expression levels after liver transplantation are at least partially due to changes in levels of NF-kappa B activity. CsA appears to downregulate NF-kappa B activity, thus inhibiting IFN-gamma gene transcription. Blocking the NF-kappa B mediated transcription pathway may be of benefit in preventing liver transplant rejection.